|4Feb 17, 5:30 PM ET

Vanda Pharmaceuticals Inc. 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 17, 2016

Insider Transaction Report

Form 4
Period: 2016-02-12
Baroldi Paolo
SVP & Chief Medical Officer
Transactions
  • Award

    Restricted Stock Unit

    2016-02-12+30,00030,000 total
    Common Stock (30,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2016-02-12+70,00070,000 total
    Exercise: $7.94Exp: 2026-02-11Common Stock (70,000 underlying)
Footnotes (4)
  • [F1]The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning March 12, 2016, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
  • [F3]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F4]Not Applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION